A vaccine for the CCP virus being developed by British scientists could arrive in the United States as early as October thanks to an acceleration made possible by the Trump administration’s new Operation Warp Speed, a program aimed at speeding up the testing, production, and deployment of vaccines against the new virus.
The Department of Health and Human Services (HHS) announced Thursday a collaboration with AstraZeneca, which obtained the license for the vaccine.
